Company intelligence / Profile preview

Medium Enterprises

San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Medium Enterprises is a biotechnology company focused on developing novel therapeutics by leveraging advanced computational biology and high-throughput screening. The company specializes in identifying cellular pathways associated with aging and metabolic health to create interventions that extend human healthspan. Their proprietary platform integrates multi-omics data to discover small molecule candidates and cell-based therapies. Medium Enterprises aims to address the root causes of chronic age-related conditions through a precision medicine approach.

Therapeutic areas: NeurologyMetabolic DisordersOther
Modalities: Small moleculeCell therapyGene therapy
Industry: Biotech

Beyond the preview

Go deeper on Medium Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medium Enterprises.

Explore the full profile